MAPT and Alzheimer disease: In contrast, radiotracers that detect amyloid-beta (Aβ) accumulation, tau protein aggregation, and neuroinflammation more directly reflect the pathological state of individuals with AD or MCI progressing to AD (cMCI) [48].